Spend $99, get free U.S. shipping*
Tariff now required on U.S. shipments. Learn more »
Tel: 1-866-456-3768 Fax: 1-866-544-8993
For visual reference only; actual product may vary
For visual reference only; actual product may vary
Incruse Ellipta is a once-daily prescription inhaler for the long-term management of COPD. Its active ingredient, umeclidinium, relaxes airway muscles, helping you breathe easier for a full 24 hours. This helps control symptoms like shortness of breath and wheezing for better daily function.
| Incruse Ellipta Brand | 55mcg 30 Doses |
-
|
Our price: $83.00 |
Incruse is a prescription maintenance inhaler used for the long-term treatment of chronic obstructive pulmonary disease (COPD). It contains the active ingredient umeclidinium, an anticholinergic medicine. This medication helps make breathing easier for people with lung diseases like emphysema or chronic bronchitis. Incruse is not a rescue inhaler. It should not be used for sudden breathing problems. It is intended for once-daily use to manage symptoms over time, providing consistent relief from airway obstruction and improving overall lung function.
Incruse works by relaxing the muscles that surround the airways in your lungs. The active ingredient, umeclidinium, blocks nerve signals that can cause these muscles to tighten. By preventing this tightening, the airways are able to stay open wider. This action allows air to flow more freely in and out of the lungs. The effect of a single dose lasts for a full 24 hours. This provides sustained improvement in breathing for people with COPD. This steady control helps to reduce symptoms like wheezing, coughing, and shortness of breath throughout the day and night.
Incruse is for adults who need a daily medication to manage chronic obstructive pulmonary disease (COPD). This includes patients diagnosed with either chronic bronchitis or emphysema. It is prescribed as a maintenance therapy to prevent and control symptoms. This medication is not suitable for treating asthma. It is also not intended for use during a sudden COPD flare-up. Your doctor will perform an evaluation. They will determine if Incruse is the right long-term treatment option for your specific health needs and condition.
Incruse is administered as one inhalation through the mouth once every 24 hours. You should use the inhaler at the same time each day for the best results. The Ellipta device comes with pre-measured doses. To use it, you slide open the cover until you hear a click. You then breathe out fully, put the mouthpiece to your lips, and take one long, steady, deep breath in. Hold your breath for about 3-4 seconds before breathing out slowly. Do not take more than one dose per day. Always use the medication as prescribed by your healthcare provider.
Incruse may cause side effects, although many people have no side effects or only minor ones. Common side effects can include cold-like symptoms, a cough, or a faster heart rate. Some people might also experience constipation or pain that could signal a sinus or urinary tract infection. In rare cases, more serious side effects can occur. These include new or worsening eye problems like glaucoma or difficulty urinating. Seek immediate help if you have an allergic reaction, such as a rash, hives, or swelling of the face and throat.
IsraelPharm is your trusted source for authentic and affordable medications like Incruse. We ensure you receive genuine products sourced from regulated suppliers. Our licensed pharmacy team is committed to your health and safety. We make managing your COPD easier with competitive prices that help you save money on your prescription. With our straightforward ordering process and reliable international shipping, your medication arrives discreetly at your door. Choose IsraelPharm for a professional, convenient, and cost-effective way to get the treatment you need.
You should stop using Incruse and get immediate medical help if you experience signs of a serious allergic reaction. These signs include:
Common side effects of Incruse Ellipta can include:
This is not a complete list of all possible side effects. For more information, please consult the medication leaflet or speak with your doctor.
Incruse Ellipta is indicated for the once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Incruse Ellipta is a prescription medication used for the long-term, once-daily maintenance treatment of chronic obstructive pulmonary disease (COPD). This includes conditions like emphysema and chronic bronchitis. It helps to relax the airway muscles, making it easier to breathe. It is not intended for the relief of sudden breathing problems and is not a rescue inhaler.
Incruse Ellipta begins to work after the first dose, helping to open airways within about 15 minutes. However, it is designed for long-term control, not immediate relief. Patients typically notice the full, stable benefit of easier breathing and symptom reduction after several days of consistent daily use. You should use it every day as prescribed to get the best results.
No, you should not use Incruse more than once a day. The medication is specifically formulated to provide 24-hour symptom relief with just a single inhalation every 24 hours. Taking more than the prescribed dose will not improve its effectiveness and can significantly increase your risk of experiencing serious side effects. Always follow your doctor’s instructions.
If you miss a dose of Incruse, you should take it as soon as you remember. However, if it is almost time for your next scheduled dose, just skip the missed one. Do not take two doses at the same time or close together to make up for the missed one. Simply resume your regular once-daily schedule.
No, Incruse Ellipta is not a steroid. It is an anticholinergic medication, with the active ingredient umeclidinium. It works by relaxing the muscles around the airways. This is a different mechanism from inhaled corticosteroids (steroids), which work by reducing inflammation. Some COPD combination inhalers contain a steroid, but Incruse does not.
Incruse can often be used with other inhalers, such as a rescue inhaler for sudden symptoms. However, you should not use it with other medicines that contain a long-acting anticholinergic, as this may increase the risk of side effects. Always inform your doctor about all the medications you are taking, including other inhalers, so they can manage your treatment safely.
The most common side effects reported with Incruse include upper respiratory tract infections, presenting as common cold symptoms like a stuffy nose or sore throat. Other frequent side effects are coughing and joint pain. These effects are typically mild and may not be experienced by everyone. If any side effect becomes severe or bothersome, you should contact your doctor.
Weight gain is not recognized as a common side effect of Incruse Ellipta. Medications that are well-known for causing weight gain, such as oral corticosteroids, work differently. As an inhaled anticholinergic, Incruse has not been linked to changes in body weight in clinical trials. If you notice significant weight changes, discuss them with your doctor to identify the cause.
There is no direct interaction listed between Incruse and alcohol. However, for people with COPD, heavy alcohol consumption can sometimes interfere with breathing or lead to other health complications. It is best to consume alcohol only in moderation. You should discuss your drinking habits with your doctor to ensure it is safe for your overall health condition.
Your Incruse Ellipta inhaler should be stored at room temperature in a dry place, away from direct heat or sunlight. It should remain in its sealed foil tray until you are ready for its first use. After you open the tray, the inhaler must be used within six weeks. Always keep the inhaler’s cover closed to protect it from dirt and moisture.
Incruse and Spiriva are both once-daily anticholinergic inhalers prescribed for COPD, but they contain different active ingredients. Incruse contains umeclidinium, while Spiriva contains tiotropium. While both work in a similar way to relax airway muscles, some patients may respond better to one than the other. Your doctor will choose the medication best suited for your specific needs.
Incruse has the potential to worsen a condition known as narrow-angle glaucoma, as it can increase pressure inside the eye. If you have a history of eye problems, you must inform your doctor before starting this medication. If you experience eye pain, blurred vision, or see halos while using Incruse, report it to your doctor immediately as it can be a medical emergency.
No, you do not need to rinse your mouth after using Incruse. Rinsing the mouth is a common instruction for inhaled corticosteroids to prevent a mouth infection called thrush. Since Incruse is an anticholinergic and does not contain a steroid, the risk of thrush is not a concern, and rinsing is not necessary.
Your Incruse Ellipta inhaler is equipped with a dose counter on the front. It shows you exactly how many doses are left in the device. The number will decrease by one each time you open the cover. When the dose counter displays a "0", the inhaler is empty, and you should dispose of it properly and start a new one.
No, Incruse is not approved for the treatment of asthma. The safety and effectiveness of Incruse in people with asthma have not been established. It is specifically a maintenance treatment for chronic obstructive pulmonary disease (COPD). Using it for asthma could be unsafe. Always use medications only as prescribed by your healthcare provider for the specified condition.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days
IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.
Hyperemesis gravidarum, or HG, is the medical name for severe morning sickness, and it can leave a pregnant woman unable to keep food or water down for weeks at a time. Metformin, a long-established diabetes
If you have been treating a chronic condition with the same prescription for a while, your daily routine probably runs on autopilot – pill in the morning, maybe another at night, and a supplement (mineral,
Irritable bowel syndrome (IBS) is a chronic digestive condition that causes recurring abdominal pain along with changes in bowel habits, including diarrhea, constipation, or both. It affects millions of adults in the United States, making
